NICE proposes restricting MS therapies
admin 21st December 2017 Uncategorised 0Novartis’ Extavia is the only beta interferon being endorsed by the National Institute for Health and Care Excellence as a cost-effective treatment option for multiple sclerosis.
More: NICE proposes restricting MS therapies
Source: News